Syra Health Corp.
SYRA
$0.3401
-$0.0189-5.27%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.25M | 1.97M | 1.75M | 1.77M | 1.58M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.25M | 1.97M | 1.75M | 1.77M | 1.58M |
| Cost of Revenue | 1.59M | 1.62M | 1.57M | 1.18M | 1.03M |
| Gross Profit | 668.30K | 350.00K | 179.30K | 582.00K | 554.50K |
| SG&A Expenses | 1.04M | 1.45M | 1.33M | 1.32M | 885.20K |
| Depreciation & Amortization | 25.50K | 17.40K | 12.50K | 12.40K | 12.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.68M | 3.36M | 3.20M | 2.75M | 1.92M |
| Operating Income | -428.90K | -1.39M | -1.44M | -986.20K | -343.00K |
| Income Before Tax | -417.50K | -1.39M | -1.45M | -995.30K | -354.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -417.50K | -1.39M | -1.45M | -995.30K | -354.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -417.50K | -1.39M | -1.45M | -995.30K | -354.40K |
| EBIT | -428.90K | -1.39M | -1.44M | -986.20K | -343.00K |
| EBITDA | -403.40K | -1.37M | -1.43M | -973.80K | -330.70K |
| EPS Basic | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| Normalized Basic EPS | -0.04 | -0.13 | -0.14 | -0.10 | -0.05 |
| EPS Diluted | -0.06 | -0.21 | -0.22 | -0.16 | -0.08 |
| Normalized Diluted EPS | -0.04 | -0.13 | -0.14 | -0.10 | -0.05 |
| Average Basic Shares Outstanding | 7.26M | 6.60M | 6.50M | 6.37M | 4.36M |
| Average Diluted Shares Outstanding | 7.26M | 6.60M | 6.50M | 6.37M | 4.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
